Search - tctmd.com

Displaying 41 - 60 of 148

Sort: Relevancy | Date

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

Wearable Devices Are Cost-effective AF Screening Tools

News Daily News

Wearable Devices Are Cost-effective AF Screening Tools

August 10, 2022

Knowns, Unknowns of Vaccine Myocarditis Risks Summarized in ‘Living’ Review

News Daily News

Knowns, Unknowns of Vaccine Myocarditis Risks Summarized in ‘Living’ Review

July 21, 2022

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

News Daily News

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

June 10, 2022

If You Smoke, Adding in E-Cigs Likely Won’t Cut CV Risks

News Daily News

If You Smoke, Adding in E-Cigs Likely Won’t Cut CV Risks

May 13, 2022

ACC Releases Guidance on CV Issues With COVID-19

News Daily News

ACC Releases Guidance on CV Issues With COVID-19

March 16, 2022

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

News Daily News

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

Michael O'Riordan

March 04, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

February 07, 2022

COVID-19: TCTMD’s Dispatch for January Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 3

January 17, 2022

Consider COVID-19 History in Pre-op CV Screening, Doctors Say

News Daily News

Consider COVID-19 History in Pre-op CV Screening, Doctors Say

January 14, 2022

CDC Extends COVID-19 Boosters to Adolescents, but Myocarditis Is Top of Mind

News Daily News

CDC Extends COVID-19 Boosters to Adolescents, but Myocarditis Is Top of Mind

January 06, 2022

COVID-19: TCTMD’s Dispatch for December Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for December Week 3

December 20, 2021

Dietary Patterns, Social Pressures: AHA Offers New Nutrition Advice

News Conference News AHA 2021

Dietary Patterns, Social Pressures: AHA Offers New Nutrition Advice

November 19, 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

News Conference News TCT 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Michael O'Riordan

November 06, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.